These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8311687)

  • 1. Nephrotoxicity and covalent binding of 1,1-dichloroethylene in buthionine sulphoximine-treated mice.
    Brittebo EB; Darnerud PO; Eriksson C; Brandt I
    Arch Toxicol; 1993; 67(9):605-12. PubMed ID: 8311687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of glutathione depletion by buthionine sulphoximine on 1-cyano-3,4-epithiobutane toxicity.
    VanSteenhouse JL; Fettman MJ; Gould DH
    Food Chem Toxicol; 1991 Mar; 29(3):153-7. PubMed ID: 2032656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of cisplatin toxicity by buthionine sulfoximine, a glutathione-depleting agent, in mice.
    Ishikawa M; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):131-41. PubMed ID: 2326543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of buthionine sulphoximine (BSO) on glutathione depletion and xenobiotic biotransformation.
    Drew R; Miners JO
    Biochem Pharmacol; 1984 Oct; 33(19):2989-94. PubMed ID: 6148944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotransformation and renal processing of nephrotoxic agents.
    Dekant W
    Arch Toxicol Suppl; 1996; 18():163-72. PubMed ID: 8678792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue-specific changes in glutathione and cysteine after buthionine sulfoximine treatment of rats and the potential for artifacts in thiol levels resulting from tissue preparation.
    Standeven AM; Wetterhahn KE
    Toxicol Appl Pharmacol; 1991 Feb; 107(2):269-84. PubMed ID: 1994510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dichlorovinyl cysteine (DCVC) in the mouse kidney: tissue-binding and toxicity after glutathione depletion and probenecid treatment.
    Darnerud PO; Brandt I; Feil VJ; Bakke JE
    Arch Toxicol; 1989; 63(5):345-50. PubMed ID: 2818197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrotoxicity of thiabendazole in mice depleted of glutathione by treatment with DL-buthionine sulphoximine.
    Mizutani T; Ito K; Nomura H; Nakanishi K
    Food Chem Toxicol; 1990 Mar; 28(3):169-77. PubMed ID: 2344991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of buthionine sulfoximine (NSC 326231) and its effect on melphalan-induced toxicity in mice.
    Smith AC; Liao JT; Page JG; Wientjes MG; Grieshaber CK
    Cancer Res; 1989 Oct; 49(19):5385-91. PubMed ID: 2766304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of modulators of glutathione synthesis on the hepatotoxicity of 2-methylfuran.
    Ravindranath V; Boyd MR
    Biochem Pharmacol; 1991 May; 41(9):1311-8. PubMed ID: 2018563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of glutathione levels on aflatoxin B1-DNA binding in livers and kidneys of male rats and hamsters pretreated with buthionine sulfoximine and dimethylmaleate.
    Gopalan-Kriczky P; Hiruma S; Lotlikar PD
    Cancer Lett; 1994 Jan; 76(1):25-30. PubMed ID: 8124663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione depletion in tissues after administration of buthionine sulphoximine.
    Minchinton AI; Rojas A; Smith KA; Soranson JA; Shrieve DC; Jones NR; Bremner JC
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1261-4. PubMed ID: 6469748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the acute toxicity of methyl chloride in male B6C3F1 mice by glutathione depletion.
    Chellman GJ; White RD; Norton RM; Bus JS
    Toxicol Appl Pharmacol; 1986 Oct; 86(1):93-104. PubMed ID: 3764938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of effect of glutathione depletion by L-buthionine-S,R-sulfoximine on gentamicin nephrotoxicity in rats.
    Wu DF; Griffith OW; Reidenberg MM
    Pharmacology; 1990; 40(5):250-7. PubMed ID: 2274571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The deleterious effect of buthionine sulfoximine, a glutathione-depleting agent, on the cisplatin toxicity in mice.
    Ishikawa M; Takayanagi Y; Sasaki K
    Jpn J Pharmacol; 1990 Apr; 52(4):652-5. PubMed ID: 2342233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cisplatin-induced nephrotoxicity in rats by buthionine sulfoximine, a glutathione synthesis inhibitor.
    Mayer RD; Lee KE; Cockett AT
    Cancer Chemother Pharmacol; 1987; 20(3):207-10. PubMed ID: 2890443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
    Kramer RA; Greene K; Ahmad S; Vistica DT
    Cancer Res; 1987 Mar; 47(6):1593-7. PubMed ID: 3815359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promotion of trans-platinum in vivo effects on renal heme and hemoprotein metabolism by D,L-buthionine-S,R-sulfoximine. Possible role of glutathione.
    Mayer RD; Maines MD
    Biochem Pharmacol; 1990 May; 39(10):1565-71. PubMed ID: 2337413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organ-selective switching of 3-methylindole toxicity by glutathione depletion.
    Yost GS; Kuntz DJ; McGill LD
    Toxicol Appl Pharmacol; 1990 Mar; 103(1):40-51. PubMed ID: 2315931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of modulation of hepatic glutathione on biotransformation and covalent binding of aflatoxin B1 to DNA in the mouse.
    Monroe DH; Eaton DL
    Toxicol Appl Pharmacol; 1988 Jun; 94(1):118-27. PubMed ID: 3131927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.